Page 7 - பல்கலைக்கழகம் ஆஃப் க்ரீஃப்ஸ்‌வால்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Science’s COVID-19 reporting is supported by the Heising-Simons Foundation. Researchers in Germany and Canada have added provocative new details to their proposal for how the COVID-19 vaccine made by AstraZeneca might be causing an unusual clotting disorder in a small number of recipients. The mechanism, involving stray human proteins and a preservative in the vaccine, remains speculative. And it is not clear whether their hypothesis explains similar reactions observed in recipients of the COVID-19 vaccine made by Johnson & Johnson (J&J). The new data are “interesting but not a smoking gun by any means” for the group’s hypothesis, says Gowthami Arepally, a hematologist at the Duke University School of Medicine who is working as an external consultant with AstraZeneca on the issue. But figuring out what in a COVID-19 vaccine might start the sometimes fatal combination of blood clotting and low platelets is crucial for developing better treatments for the side effect and po

Mecklenburg vorpommernUnited statesRolf marschalekEmer cookeYu xuefengGowthami arepallyMortimer ponczKai kupferschmidtPaul offitAndreas greinacherGretchen vogelCansino biologicsHeising simons foundationDuke university school of medicineGoethe university frankfurtRussian gamaleya national research institute of epidemiology